CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as ...

Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know ...

Antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines, according to a new study from the Perelman School ...

Sarbecoviruses—the group of coronaviruses that includes both SARS-CoV-1 and SARS-CoV-2—have long circulated in horseshoe bats across Western China and Southeast Asia.

In the SARS-CoV-2 Immunity and Reinfection Evaluation (SIREN) study, which involved a large cohort of asymptomatic health care workers who underwent polymerase-chain-reaction (PCR) testing every 2 ...

The results showed that both SARS-CoV and SARS-CoV-2 envelopes have a spherical morphology, with the structural proteins forming multiple string-like islands in the membrane and clusters between ...

A SARS-CoV-2 risk-monitoring and evaluation framework is being developed and continually improved by the WHO to identify and assess variants of concern.

SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Nature Communications, 2021; 12 (1) DOI: 10.1038/s41467-021-26910-8 ...

One of the isolates, RmYN02 is remarkably similar to SARS-2 (93.3% overall). That part of the virus which specifies the enzymes required for replication showed an even greater similarity (97.2%).